ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Claritas Pharmaceuticals Inc

Claritas Pharmaceuticals Inc (CLAS)

0,025
0,00
(0,00%)
Fermé 30 Novembre 10:00PM

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Statistiques et détails clés

Dernier
0,025
Prix Achat
0,025
Prix Vente
0,035
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,025 Plage de 52 semaines 0,025
Clôture Veille
0,025
Ouverture
-
Dernière Transaction
Dernière heure de transaction
Volume moyen (3 m)
-
Volume financier
-
VWAP
-

CLAS Dernières nouvelles

Claritas Announces Approval from OTC to Up-List to OTCQB

SAN FRANCISCO, CA and TORONTO, ON, April 07, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") is pleased to...

Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107

SAN FRANCISCO, CA and TORONTO, ON, April 05, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE EXCHANGE: CLAS and OTC: CLAZF) (the "Company" or "Claritas") today announced...

Claritas Announces Receipt of Comments from Australian Ethics Committee Regarding the Company’s Phase 1 Clinical Study of R-107 and Closing of Financing

SAN FRANCISCO, CA and TORONTO, ON , Feb. 22, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today announced that it has...

Claritas Anticipates Response from Australian Ethics Committee by February 18, 2022

SAN FRANCISCO, CA and TORONTO, ON, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today announced that the...

Claritas Announces Revised, Improved Terms for Initial Tranche of Financing with Alumina Partners

SAN FRANCISCO, CA and TORONTO, ON, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas”) today announced revised...

Claritas Announces Letter of Intent to Acquire Worldwide Rights to R-107 for Treatment of Wound Healing, Skin Ulcers and Severe Burns

SAN FRANCISCO, CA and TORONTO, ON, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: KLY and OTC: KALTF) (the "Company" or "Claritas") today announced that it has...

Claritas Announces New Registered and Records Office Address, Confirms its Management and Directors and Announces Terms of Initial Tranche of Equity Financing with Alumina Partners

SAN FRANCISCO, CA and TORONTO, ON, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today announced the Company’s...

Claritas Secures $5 Million Equity Financing Facility with Alumina Partners (Ontario) Ltd.

SAN FRANCISCO, CA and TORONTO, ON, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") is pleased to announce it has...

Claritas Outlines Development Strategy for R-107 for Multiple Diseases, Disorders and Injuries

SAN FRANCISCO, CA and TORONTO, ON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today outlined the Company’s...

Claritas to Develop R-107 for Treatment of PPHN, a Potentially Fatal Pulmonary Disorder in Newborns

SAN FRANCISCO, CA, and TORONTO, ON, Dec. 22, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the "Company" or "Claritas") today announced that it will...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.0250.0250.02500CS
4000.0250.0250.02500CS
12000.0250.0250.02500CS
26000.0250.0250.02500CS
52000.0250.0250.02500CS
156-0.135-84.3750.160.250.025131590.1129606CS
260-0.025-500.050.750.021427930.05612178CS

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ENTGEntourage Health Corp
$ 0,015
(200,00%)
2,18M
ACAP.PAtlas One Capital Corporation
$ 0,015
(200,00%)
221,8k
SSESilver Spruce Resources Inc
$ 0,01
(100,00%)
18,01k
XCAP.PExelerate Capital Corp
$ 0,05
(66,67%)
129k
POOLPool Safe Inc
$ 0,04
(60,00%)
158,3k
WWTWater Ways Technologies Inc
$ 0,005
(-50,00%)
52,11k
OSIXOceansix Future Paths Ltd
$ 0,005
(-50,00%)
2,12M
JHCJinhua Capital Corporation
$ 0,005
(-50,00%)
140k
DMDataMetrex AI Limited
$ 0,005
(-50,00%)
130k
MDK.PMDK Acquisition Inc
$ 0,05
(-50,00%)
5k
EGTEguana Technologies Inc
$ 0,01
(0,00%)
2,55M
ENTGEntourage Health Corp
$ 0,015
(200,00%)
2,18M
OSIXOceansix Future Paths Ltd
$ 0,005
(-50,00%)
2,12M
RIORio2 Limited New
$ 0,63
(-4,55%)
2,11M
GBUGabriel Resources Ltd
$ 0,015
(0,00%)
2,02M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées